Optimizing Implementation of Long Acting Injectable PrEP

ConditionHIV Infections

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Minnesota

About this trial

Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years of age or older,

affiliated with a participating clinic, and

be involved in prescribing or supporting PrEP care delivery.

Disqualifiers

17 years of age or younger,

not affiliated with a participating clinic, and

not involved in prescribing or supporting PrEP care delivery.

16 years of age or older, and

Trial design

Design model

Crossover

Treatments tested in this trial

Plan-Do-Study-Act
Behavioral
Implementation strategy of conducting cyclical small tests of change using Plan-Do-Study-Act

Treatment groups

20 Participants

are divided into 2 treatment groups

Group A: Clinic ImplementationActive comparator 1 intervention

Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

LAI-PrEP prescribing

Proportion of eligible patients prescribed LAI-PrEP

Time frame

3 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Minnesota

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: